|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 126, Issue 7 1397-1406, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
TS Zorick, DE Syroid, A Brown, T Gridley and G Lemke
Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA 92037, USA.
The transcription factors Krox-20 and SCIP each play important roles in the differentiation of Schwann cells. However, the genes encoding these two proteins exhibit distinct time courses of expression and yield distinct cellular phenotypes upon mutation. SCIP is expressed prior to the initial appearance of Krox-20, and is transient in both the myelinating and non-myelinating Schwann cell lineages; while in contrast, Krox-20 appears approximately 24 hours after SCIP and then only within the myelinating lineage, where its expression is stably maintained into adulthood. Similarly, differentiation of SCIP-/- Schwann cells appears to transiently stall at the promyelinating stage that precedes myelination, whereas Krox-20(-/-) cells are, by morphological criteria, arrested at this stage. These observations led us to examine SCIP regulation and Schwann cell phenotype in Krox-20 mouse mutants. We find that in Krox-20(-/-) Schwann cells, SCIP expression is converted from transient to sustained. We further observe that both Schwann cell proliferation and apoptosis, which are normal features of SCIP+ cells, are also markedly increased late in postnatal development in Krox-20 mutants relative to wild type, and that the levels of cell division and apoptosis are balanced to yield a stable number of Schwann cells within peripheral nerves. These data demonstrate that the loss of Krox-20 in myelinating Schwann cells arrests differentiation at the promyelinating stage, as assessed by SCIP expression, mitotic activity and susceptibility to apoptosis.
This article has been cited by other articles:
|
|
 |
|
  G. M. Mager, R. M. Ward, R. Srinivasan, S.-W. Jang, L. Wrabetz, and J. Svaren Active Gene Repression by the Egr2{middle dot}NAB Complex during Peripheral Nerve Myelination J. Biol. Chem., June 27, 2008; 283(26): 18187 - 18197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Desmazieres, L. Decker, J.-M. Vallat, P. Charnay, and P. Gilardi-Hebenstreit Disruption of Krox20-Nab Interaction in the Mouse Leads to Peripheral Neuropathy with Biphasic Evolution J. Neurosci., June 4, 2008; 28(23): 5891 - 5900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Ryu, J. Y. T. Wang, N. Le, R. H. Baloh, J. A. Gustin, R. E. Schmidt, and J. Milbrandt Misexpression of Pou3f1 Results in Peripheral Nerve Hypomyelination and Axonal Loss J. Neurosci., October 24, 2007; 27(43): 11552 - 11559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. LeBlanc, R. M. Ward, and J. Svaren Neuropathy-Associated Egr2 Mutants Disrupt Cooperative Activation of Myelin Protein Zero by Egr2 and Sox10 Mol. Cell. Biol., May 1, 2007; 27(9): 3521 - 3529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. LeBlanc, S.-W. Jang, R. M. Ward, L. Wrabetz, and J. Svaren Direct Regulation of Myelin Protein Zero Expression by the Egr2 Transactivator J. Biol. Chem., March 3, 2006; 281(9): 5453 - 5460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-M. Yu, M. L. Feltri, L. Wrabetz, S. Strickland, and Z.-L. Chen Schwann Cell-Specific Ablation of Laminin {gamma}1 Causes Apoptosis and Prevents Proliferation J. Neurosci., May 4, 2005; 25(18): 4463 - 4472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Le, R. Nagarajan, J. Y. T. Wang, T. Araki, R. E. Schmidt, and J. Milbrandt Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination PNAS, February 15, 2005; 102(7): 2596 - 2601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Parkinson, A. Bhaskaran, A. Droggiti, S. Dickinson, M. D'Antonio, R. Mirsky, and K. R. Jessen Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death J. Cell Biol., February 2, 2004; 164(3): 385 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H.G. Verheijen, R. Chrast, P. Burrola, and G. Lemke Local regulation of fat metabolism in peripheral nerves Genes & Dev., October 1, 2003; 17(19): 2450 - 2464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Slutsky, A. K. Kamaraju, A. M. Levy, J. Chebath, and M. Revel Activation of Myelin Genes during Transdifferentiation from Melanoma to Glial Cell Phenotype J. Biol. Chem., March 7, 2003; 278(11): 8960 - 8968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ghislain, C. Desmarquet-Trin-Dinh, M. Jaegle, D. Meijer, P. Charnay, and M. Frain Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development Development, January 1, 2002; 129(1): 155 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Sherman, T. A. Rizvi, S. Karyala, and N. Ratner CD44 Enhances Neuregulin Signaling by Schwann Cells J. Cell Biol., September 5, 2000; 150(5): 1071 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. Peirano, D. E. Goerich, D. Riethmacher, and M. Wegner Protein Zero Gene Expression Is Regulated by the Glial Transcription Factor Sox10 Mol. Cell. Biol., May 1, 2000; 20(9): 3198 - 3209. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Stevens and R. D. Fields Response of Schwann Cells to Action Potentials in Development Science, March 24, 2000; 287(5461): 2267 - 2271. [Abstract] [Full Text]
|
|
|
|
|
|
L. Wrabetz, M. L. Feltri, A. Quattrini, D. Imperiale, S. Previtali, M. D'Antonio, R. Martini, X. Yin, B. D. Trapp, L. Zhou, et al. P0 Glycoprotein Overexpression Causes Congenital Hypomyelination of Peripheral Nerves J. Cell Biol., March 6, 2000; 148(5): 1021 - 1034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Garratt, O. Voiculescu, P. Topilko, P. Charnay, and C. Birchmeier A Dual Role of erbB2 in Myelination and in Expansion of the Schwann Cell Precursor Pool J. Cell Biol., March 6, 2000; 148(5): 1035 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Warner, J. Svaren, J. Milbrandt, and J. R. Lupski Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies Hum. Mol. Genet., July 1, 1999; 8(7): 1245 - 1251. [Abstract] [Full Text] [PDF]
|
|
